Telix Pharmaceuticals Limited Share Price
Stocks
TLX
AU000000TLX2
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Australian S.E.
10:40:20 08/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 15.85 AUD | -0.13% |
|
+0.83% | +41.52% |
| 11/09 | ASX Biggest Losers | MT |
| 03/09 | ASX Biggest Gainers | MT |
| Market Cap | 538.56Cr 374.54Cr 334.47Cr 312.02Cr 283.44Cr 533.36Cr 36TCr 3.75TCr 1.47TCr 18TCr 1.41TCr 1.38TCr 59TCr | P/E 2026 * |
223x | P/E 2027 * | 964x |
|---|---|---|---|---|---|
| Enterprise Value | 589.98Cr 410.3Cr 366.4Cr 341.81Cr 310.5Cr 584.29Cr 40TCr 4.1TCr 1.61TCr 20TCr 1.54TCr 1.51TCr 65TCr | EV / Sales 2026 * |
4.25x | EV / Sales 2027 * | 3.71x |
| Free-Float |
84.32% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| TLX | Delayed | |
Deutsche Boerse AG
| T3X | Delayed | |
|
Tradegate
| T3X | Real-time | |
|
OTC Markets
| TLPPF | Delayed | |
|
Boerse Muenchen
| T3X | Real-time | |
|
Börse Stuttgart
| T3X | Delayed |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | -0.13% | ||
| 1 week | +0.83% | ||
| Current month | +0.83% | ||
| 1 month | -2.46% | ||
| 3 months | -6.16% | ||
| 6 months | +16.72% | ||
| Current year | +41.52% |
| 1 week | 14.88 |  | 16.27 |
| 1 month | 14.88 | | 18.22 |
| Current year | 8.26 | | 18.22 |
| 1 year | 8.26 | | 18.22 |
| 3 years | 8.2 | | 31.97 |
| 5 years | 3.55 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 03/01/2017 | |
Darren Smith
DFI | Director of Finance/CFO | 61 | 31/07/2022 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 03/01/2017 | |
Mark Nelson
CHM | Chairman | 66 | 03/02/2026 |
Jann Skinner
BRD | Director/Board Member | 68 | 19/06/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 24/09/26 | Buy | Chairman | 11,800 | 0.0035% | ||
| 07/09/26 | Buy | Chief Financial Officer | 2,071 | 0.0006% | ||
| 26/05/26 | Free | Director | 21,597 | 0.0064% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.13% | +0.83% | +4.48% | +40.89% | 375.33Cr | |
| -3.19% | -3.19% | +44.60% | +87.98% | 7.47TCr | |
| -15.86% | -16.16% | +2.68% | +51.09% | 5.87TCr | |
| -2.39% | +0.50% | +3.41% | +31.33% | 4.84TCr | |
| -6.38% | -8.66% | +293.25% | +638.32% | 4.31TCr | |
| +0.33% | -0.68% | +29.08% | +29.77% | 4.25TCr | |
| -3.83% | -2.43% | -0.30% | +102.58% | 4.14TCr | |
| -2.13% | +1.07% | +7.51% | +50.31% | 3.13TCr | |
| -3.36% | -5.13% | -13.54% | -15.94% | 2.39TCr | |
| -1.21% | -7.69% | -38.05% | +308.96% | 2.22TCr | |
| Average | -3.84% | -2.27% | +33.31% | +132.53% | 3.9TCr | |
| Weighted average by Cap. | -4.83% | -1.85% | +42.54% | +134.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 138.77Cr 97Cr 86Cr 80Cr 73Cr 137.43Cr 9.35TCr 965.26Cr 377.54Cr 4.75TCr 362.35Cr 354.48Cr 15TCr | 158.1Cr 109.95Cr 98Cr 92Cr 83Cr 156.58Cr 11TCr 1.1TCr 430.14Cr 5.41TCr 412.84Cr 403.87Cr 17TCr |
| Net income | 2.94Cr 2.05Cr 1.83Cr 1.71Cr 1.55Cr 2.92Cr 198.36Cr 20Cr 8.01Cr 100.79Cr 7.69Cr 7.52Cr 324.16Cr | 61.68L 42.9L 38.31L 35.74L 32.46L 61.09L 42Cr 4.29Cr 1.68Cr 21Cr 1.61Cr 1.58Cr 68Cr |
| Net Debt | 51Cr 36Cr 32Cr 30Cr 27Cr 51Cr 3.46TCr 357.66Cr 139.89Cr 1.76TCr 134.26Cr 131.35Cr 5.66TCr | 48Cr 33Cr 30Cr 28Cr 25Cr 47Cr 3.2TCr 330.54Cr 129.28Cr 1.63TCr 124.08Cr 121.39Cr 5.23TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/26/08 | A$15.85 | -0.13% | 12,97,945 |
| 07/26/07 | A$15.87 | +2.99% | 23,64,422 |
| 06/26/06 | A$15.41 | -0.90% | 11,14,504 |
| 05/26/05 | A$15.55 | +2.57% | 12,68,082 |
| 02/26/02 | A$15.16 | -2.88% | 25,79,339 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
